Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy

• Status: Unknown status
• Trial end date: 2019-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The clinical trial is a stage 3 study to determine the role of fentanyl transmucosal in the prevention of pain induced by mobilization in patients receiving a bone metastasis radiation for bone metastasis irradiations

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre Henri Becquerel
• Treatments: Fentanyl

Criteria

Inclusion Criteria:

• Male or female

• More than 18 years old

• Proven histological cancer with bone metastasis

• SignedInform consent form

• Patient with pain assed as VAS Superior to 3 when positioning the patient in the preliminary scanner session

Exclusion Criteria:

• VAS>3 before radiotherapy treatment (establishment of an appropriate analgesic treatment) (session

• Any SAO treatment on going

• Pregnant or lactating woman

• Hypersensitivity or safety issues to any opioïd treatment

• Poor nasal mucosa (defined on clinical doctor assessment)

• Severe obstructive lung conditions or respiratory depression

• Renal insufficiency with creatinine clearance inferior to 45 ml/min

• Hepatic insufficiency

• Patient misunderstanding of the content and objective of the trial

• Patient under supervision or guardianship

• SAO intake 4 hours before the radiotherapy session

• Patient participating to any other pain management trial

• Morphine pump usage